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Introduction

Purpose / Hypothesis

The innate immune response is the first line of defense
against pathogens. The response is non-specific in that patterns
rather than specific molecules, are detected. White blood cells,
including monocytes, express cell-surface proteins that detect
pathogens and initiate an immune response.

A recent study by this laboratory showed that the expression
of Basigin and MCT1 transcripts is significantly decreased in
monocytes treated with LPS for 24 hours.

Toll-like receptors (TLRs) are a major group of pattern
recognition receptors (PRRs) expressed on the surface of a
variety of cells that function to recognize molecular patterns
associated with all classes of pathogenic microorganisms
(reviewed by Kawasaki et al., 2014). TLR4 specifically recognizes
the lipopolysaccharide (LPS) component of Gram-negative
bacterial cell walls.
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Expression of Basigin (A) and MCT1 (B) transcripts in RAW 264.7 cells.
The open bars represent D-PBS-treatment and the gray bars represent
LPS-treatment. The error bars represent the Coefficient of Variation.
*=p<0.05 via T-test

TLR4 has leucine-rich repeats in the extracellular
domain, a single-pass transmembrane domain,
and a toll-interferon receptor (TIR) domain in the
cytoplasmic tail

The purpose of the present study was to determine if MCT1
protein expression is also decreased after 24 hours of exposure
to LPS. Additionally, the expression of the glucose transporter
GLUT1 was assessed.

Basigin (CD147) is a member of the immunoglobulin
superfamily (IgSF) that functions as a cell adhesion molecule. It
has been implicated in a variety of processes, including
reproduction and development, metabolism, and cancer
(reviewed by Muramatsu, 2016).

It was hypothesized that MCT1 proteins would be decreased
in LPS-treated cells, when compared to the D-PBS treated cells.
Additionally, it was hypothesized that the decrease in MCT1
expression would result in the concomitant increase in GLUT1
expression to indicate a metabolic shift in response to the
inflammatory stimulus.

Basigin (CD147) has two extracellular Ig
domains, a single-pass transmembrane domain,
and a short cytoplasmic tail
A recent study by this laboratory suggests that TLR4 and
Basigin interact via their transmembrane domains (Brown, 2016,
UNF Graduate thesis).

C

*

Figure 1. Expression of MCT1 in RAW 264.7 cells as measured
by immunocytochemistry. Images of D-PBS treated (A) and LPS
treated (B) RAW 264.7 cells are shown. The magnification bar is
equal to 50 µm. (C) The relative fluorescence units corresponds
to the amount of MCT1 expression in each group at 24 hours of
treatment. The gray bars represent D-PBS-treatment and the
blue bars represent LPS-treatment. The values represent the
average of 50 regions of interest (ROIs) and the error bars
represent the standard error of the mean. * = p<0.05 via T-test.
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Methodology
Studies of the neural retina indicate that Basigin gene
expression is linked to expression of Monocarboxylate
Transporter 1 (MCT1), which moves lactate, pyruvate, and ketone
bodies across the plasma membrane via facilitated diffusion
(Philp et al., 2003; Halestrap and Price, 1999). Basigin-null mice
do not express Basigin or MCT1 on photoreceptors or Müller
cells, which impairs delivery of metabolites from the Müller cells
to the photoreceptor cells (Philp et al., 2003). The result is
blindness in Basigin-null mice from the time of eye opening
(Ochrietor et al., 2002).

Wilson et al., 2002

Philp et al., 2003

Ochrietor et al., 2002
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The cells were treated with LPS (1 µg/mL; InvivoGen, San
Diego, CA) or Dulbecco’s phosphate buffered saline (D-PBS;
Gibco – Life Technologies) for 24 hours at 37oC in 5% CO2.
The cells were subjected to immunocytochemistry (Tokar et
al., 2017) using antibodies specific for MCT1 and GLUT1
(Millipore Corporation, Billerica, MA). The cells were visualized
on an Olympus FV1000 microscope and fluorescence was
quantified using the accompanying software. Expression in LPStreated cells versus D-PBS-treated cells was compared using a
paired, one-tailed T test.

Conclusions and Comments
Although it was initially hypothesized that metabolic
responses would increase in monocytes to support immune
mechanisms, the data for MCT1 suggest that metabolism is
reduced in activated monocytes. To determine if the decrease in
MCT1 expression indicates a shift of resources from general
cellular maintenance to induction of an innate immune response,
the expression of the glucose transporter GLUT1 was also
investigated.
The expression of MCT1 is much greater than that of GLUT1.
as measured by immunohistochemistry.
This implies that
monocarboxylates like pyruvate, lactate, and ketone bodies are
transported into circulating monocytes to a greater degree than
glucose.

RAW 264.7 monocytes were grown at 37oC in 5% CO2 in
RPMI 1640 medium (Gibco – Life Technologies, Grand Island,
NY) containing 10% FBS (HyClone, GE Healthcare-BioSciences,
Marlborough, MA).
RAW 264.7 cells were plated in serum-free RPMI 1640
medium (Gibco – Life Technologies) and allowed to attach.

Figure 3. Expression of MCT1 and GLUT1 in RAW 264.7 cells as
measured by immunocytochemistry. The fluorescence units
corresponds to the level of expression of each protein in RAW
246.7 cells incubated in D-PBS. The values represent the
average of 50 regions of interest (ROIs) and the error bars
represent the standard error of the mean. * = p<0.05 via T-test.

Figure 2. Expression of GLUT1 in RAW 264.7 cells as measured
by immunocytochemistry. Images of D-PBS treated (A) and LPS
treated (B) RAW 264.7 cells are shown. The magnification bar is
equal to 50 µm. (C) The relative fluorescence units corresponds
to the amount of MCT1 expression in each group at 24 hours of
treatment. The gray bars represent D-PBS-treatment and the
blue bars represent LPS-treatment. The values represent the
average of 50 regions of interest (ROIs) and the error bars
represent the standard error of the mean. * = p<0.05 via T-test.

The expression of GLUT1 did increase in monocytes in
response to LPS treatment. This suggests that monocytes shift
their metabolic resources during an immune response to use
glucose more prevalently than monocarboxylates.
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